MLL gene is made up of 14 exons, encoding the histone lysine methyltransferase whereby it is also called KMT2A, which harbors powerful transforming potential associated with neoplastic diseases assisted by specific partners, such as AF9 (MLLT3), AF4, and ENL (MLLT1) (145). This evidence concerns the gene KMT2A and neoplasm.